Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New license

In this discussion, you guys are overlooking one pertinent thing (from RG's letter):

"Finally the company believes that it may, if needed, borrow against these securities and were investigating these programs further in the event we need to access cash in this manner before redemption can be accomplished."

So no M&A acquisitrion opportunity will be lost over this.

BTW, I suggested exactly what RG suggests above - and I got shot down. Golly, and I was right about something!

SGE

Share
New Message
Please login to post a reply